Y. Nakai

发表

Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients

Kana Takahashi, H. Igaki, J. Itami, 2020, Breast Cancer.

Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases.

Y. Fujisawa, H. Uchi, S. Matsushita, 2021, European journal of cancer.

Ipilimumab-induced hypophysitis involving the optic tracts and tuber cinereum evaluated using 3D fluid-attenuated inversion recovery

M. Maeda, H. Sakuma, M. Umino, 2017, Radiology case reports.

Cytokeratin and filaggrin expression in nevus comedonicus

K. Nishimura, A. Hakamada, K. Isoda, 2007, Journal of cutaneous pathology.

Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting

K. Yamanaka, Ayaka Ueki, Ryohei Ishiura, 2021, Case Reports in Dermatology.

Whether to maintain or strengthen the treatment for pyoderma gangrenosum ulcerative type may depend on the response after two to four‐week treatment intervention: The outcome of three cases with details clinical course

N. Yokota, K. Yamanaka, K. Habe, 2021, Clinical case reports.

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients.

S. Fukushima, Y. Kiniwa, N. Yamazaki, 2022, European journal of cancer.

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

S. Fukushima, Y. Kiniwa, S. Saito, 2021, ESMO open.

Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab

Y. Yamaguchi, H. Wakabayashi, A. Hayashi, 2019, Case Reports in Dermatology.

Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study.

S. Fukushima, Y. Kiniwa, N. Yamazaki, 2021, European journal of cancer.

Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: A multi‐institutional study of 450 patients in Japan

Yuhei Yamamoto, H. Iizuka, F. Otsuka, 2012, The Journal of dermatology.

Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)

Y. Ohe, Toshiaki Takahashi, N. Yamazaki, 2020, Supportive Care in Cancer.

Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption

Y. Ohe, Takahiro Mori, N. Yamazaki, 2018, The Journal of dermatology.

Development of cutaneous squamous cell carcinoma during pembrolizumab therapy

M. Ikejiri, K. Nakatani, K. Yamanaka, 2020, The Journal of dermatology.

Voriconazole-Induced Squamous Cell Carcinoma after Hematopoietic Stem Cell Transplantation Showing Early-Stage Vascular Invasion

N. Yokota, A. Hayashi, K. Yamanaka, 2020, Dermatopathology.

Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients

Y. Kiniwa, N. Yamazaki, A. Otsuka, 2023, Frontiers in medicine.

Reduction in Tumor Lesions and Exacerbation of Psoriatic Rash after Septic Shock in a Patient with Extramammary Paget's Disease

K. Yamanaka, K. Habe, M. Kondo, 2021, Case Reports in Oncology.

Progressive vitiligo induced by recurrent melanoma

K. Yamanaka, Y. Nakai, Ayaka Ueki, 2022, Clinical case reports.